Sorafenib Impurity 43 |
索拉非尼布杂质 |
757251-59-5 |
2-[2-bromo-4-(propan-2-yl)phenoxy]-N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide |
VU0134992 |
755002-90-5 |
1,4-Diazabicyclo[3.2.2]non-4-yl[5-[3-(trifluoromethyl)phenyl]-2-furanyl]methanone hydrochloride |
753499-14-8 |
753499-14-8 |
6-methoxy-3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinolin-2(1H)-one |
6-methoxy-3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinolin-2(1H)-one |
714932-54-4 |
4H,6H-furo[3,4-c][1,2,5]oxadiazol-4-one |
呋喃并[3,4-C][1,2,5]噁二唑-4(6H)-酮 |
73314-58-6 |
2-(1H-indol-3-yl)-2-oxo-N-phenylacetamide |
WAY-311727 |
73031-16-0 |
2-ACETYL-4-METHYLTHIAZOLE, 97% |
1-(4-甲基噻唑-2-基)乙酮 |
7533-07-5 |
Benzenemethanamine, 4-bromo-N-methyl-N-2-propyn-1-yl- |
(4-溴苯基)甲基](甲基)(丙-2-炔-1-基)胺 |
709-85-3 |
Kv2-IN-A1 |
化合物RY785 |
689297-68-5 |
4-(2-methoxyphenyl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]-6-(trifluoromethyl)pyrimidine |
4-(2-甲氧基苯基)-2-[4-(2-甲氧基苯基)哌嗪-1-基]-6-三氟甲基嘧啶 |
686725-20-2 |
BMS 986187 |
BMS 986187 |
684238-37-7 |
ML 00253764 Hydrochloride |
ML 00253764 Hydrochloride |
681847-92-7 |
(1-Phenyl-ethyl)-(2-piperazin-1-yl-quinazolin-4-yl)-amine |
2-甲氧基-4-(4-甲基哌嗪-1-基)苯胺 |
662164-09-2 |
[1-(2,5-dimethylbenzyl)-1H-benzimidazol-2-yl]methanol |
[1-(2,5-dimethylbenzyl)-1H-benzimidazol-2-yl]methanol |
637324-45-9 |
8-ethyl-5-oxo-2-[4-[[3-(trifluoromethyl)phenyl]carbamothioyl]piperazin-1-yl]pyrido[2,3-d]pyrimidine-6-carboxylic acid |
ML328 |
634175-34-1 |
XR9576 |
TARIQUIDAR 二甲磺酸盐六水合物 |
625375-83-9 |
Tradipitant |
TRADIPITANT |
622370-35-8 |
4-[4-phenyl-6-(trifluoromethyl)pyrimidin-2-yl]morpholine |
4-(4-苯基-6-(三氟甲基)嘧啶-2-基)吗啉 |
615273-95-5 |
AM4113 |
CB1 ANTAGONIST 2 |
614726-85-1 |
5'-Deoxy-5'-iodoguanosine |
5'-脱氧-5'-碘鸟苷 |
68200-68-0 |